<?xml version="1.0" encoding="UTF-8"?>
<p>This discrepancy may lie in the chosen instrumental variable and sample sizes. Genetically determined urate levels are largely defined by variation in 
 <italic>SLC2A9</italic> and 
 <italic>ABCG2</italic>, which together explain ∼3.4% of serum urate concentration (
 <xref rid="fcaa031-B55" ref-type="bibr">Köttgen 
  <italic>et al.</italic>, 2013
 </xref>). Most of the early MR studies of urate used SNPs in 
 <italic>SLC2A9</italic> only (
 <xref rid="fcaa031-B29" ref-type="bibr">Facheris 
  <italic>et al.</italic>, 2011
 </xref>; 
 <xref rid="fcaa031-B32" ref-type="bibr">Gao 
  <italic>et al.</italic>, 2013
 </xref>, Simon 
 <italic>et al.</italic>, 2014). Kia 
 <italic>et al.</italic> used GWAS-identified SNPs that explain 7% of urate variability and a two-sample MR design combining two large-scale GWAS studies, both of which improve statistical power (
 <xref rid="fcaa031-B53" ref-type="bibr">Kia 
  <italic>et al.</italic>, 2018
 </xref>).
</p>
